Document is current
Any future updates will be listed below
-
Authors
Oguri, Noriaki https://orcid.org/0000-0001-8243-6059
Kobayashi, Chie
Ozawa, Yuri https://orcid.org/0000-0003-1586-9668
Kimura, Toshihiko
Nishinarita, Yuu
Wada, Haruka
Nemoto, Nobuki
Narita, Masami
Tanigaki, Shinji
Hanawa, Tomoko https://orcid.org/0000-0003-4853-1807
Miyoshi, Jun https://orcid.org/0000-0002-6883-1930
Hisamatsu, Tadakazu https://orcid.org/0000-0002-1178-3536
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 19 August 2025
First Online: 10 September 2025
Competing interests
: J.M. has received lecture fees from EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co., Ltd., Nippon Kayaku Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. M.N. has received lecture fees from Miyarisan Co., Ltd. T.Hisamatsu. has received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd., Boston Scientific Corporation, and Kissei Pharmaceutical Co., Ltd; received consulting fees from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Eli Lilly, Gilead Sciences, Bristol Myers Squibb, and Abivax; and received lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., and Kissei Pharmaceutical Co., Ltd. The remaining authors declare no competing interests.
